We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
UK-based pharmaceutical major GlaxoSmithKline Plc Monday reported encouraging results of the phase III clinical trials of its experimental drug, eltrombopag.
Israeli drug company Intec Pharma has signed an agreement with two leading North American dosage form manufacturers -- Canadian company BioEnvelop Agro and U.S. company Tapemark -- in order to scale up the company's manufacturing platform.
Eli Lilly's antidepressant Prozac does not lower risk of relapse or help anorexia nervosa patients who have restored their body weight maintain it, according to a study published in the Journal of the American Medical Association.
Swiss drugmaker Novartis' investigational drug Tasigna helped more than 90 percent of patients diagnosed with an unresponsive form of leukemia, according to a clinical trial published in the New England Journal of Medicine.
Japanese drugmaker Dainippon Sumitomo is preparing to release AmBisome 50 mg for intravenous drip infusion, an antifungal agent for treating deep-seated mycosis infection, the company announced.
Jubilant Organosys seems to have identified the New Jersey based NYSE-listed life-sciences company, Cambrex, as one of its potential acquisition targets, as it looks for big buys in the US and Europe.
Eurofins Scientific strengthens its position in the global clinical trials market, and expands its testing services portfolio to the pharmaceutical and biotechnology industries with the acquisition of Focus Bio-Inova (FBI).
Wockhardt Ltd's UK-based subsidiary Wockhardt UK Ltd will commission a new facility to expand its Byetta (Exenatide) cartridges manufacturing capacity.